VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

40 hedge funds and large institutions have $9.58M invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$36.9K
2
+$24.1K
3
+$17.9K
4
WA
WealthTrust Axiom
Pennsylvania
+$11.6K
5
MCM
MAI Capital Management
Ohio
+$8.81K

Top Sellers

1
-$172K
2
-$145K
3
-$57.8K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$54.2K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$23.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7.42K
27
$4K
28
$3.77K
29
$3.06K
30
$3K
31
$2K
32
$1K
33
$735
34
$392
35
$204
36
$97
37
$14
38
$8
39
$5
40
$2
41
–
42
–
43
–
44
–
45
–
46
–
1
2